RxDoctor Payments Data

Adam Corn, DO

Family Medicine · Asheville, NCNPI 1285989210

Payments from drug & device makers

$858in general payments, 2019–2025

Across 72 payments — averaging $11.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$162
  • Novo Nordisk$145
  • Pfizer$133
  • Boehringer Ingelheim$120
  • GSK$93
  • AstraZeneca$71
  • plus $134 from 8 others

What the payments were for

  • Food & beverage$858100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$858 in reported general payments places this provider in the 65th percentile of 3,444 family medicine providers in North Carolina.

See all family medicine providers in North Carolina

Medicare billing

Part B allowed, 2024
$63,938
Medicare patients
275
Services billed
892

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin87$97,607
OzempicSemaglutide46$78,655
EliquisApixaban71$74,341
XareltoRivaroxaban37$49,563
TradjentaLinagliptin43$30,604
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog12$19,580
JanuviaSitagliptin Phosphate17$17,826
Trelegy ElliptaFluticasone/Umeclidin/Vilanter19$15,611
FarxigaDapagliflozin Propanediol15$13,589
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr21$11,025
SymbicortBudesonide/Formoterol Fumarate18$5,442
Atorvastatin Calcium399$2,474
Losartan Potassium219$1,888
Albuterol Sulfate HfaAlbuterol Sulfate76$1,547
Gabapentin94$1,525

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Tradjenta$120$128,211130 claims
Novo NordiskOzempic$145$78,65546 claims
PfizerEliquis$133$74,34171 claims
Johnson & JohnsonXarelto$27$49,56337 claims
GSKTrelegy Ellipta, Anoro Ellipta$93$26,63640 claims
AstraZenecaFarxiga, Symbicort$71$19,03133 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 3,444 family medicine providers in North Carolina.

Other family medicine in Asheville

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →